SCYX Q4 2019 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-1.48

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$441,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$44M

Stockholders' Equity

$13M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$64,000	-100.0%
Gross Profit	$0	$64,000	-100.0%
Operating Income	-$14M	-$9M	-60.5%
Net Income	-$14M	$2M	-844.5%